Low cancer risk in Down's syndrome linked to Ets2 gene

被引:0
|
作者
Sharma, Sharan Prakash
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:634 / 634
页数:1
相关论文
共 50 条
  • [1] Low cancer risk in Down's syndrome linked to Ets2 gene
    Sharma, Sharan Prakash
    [J]. LANCET ONCOLOGY, 2008, 9 (02): : 99 - 99
  • [2] Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice
    Sumarsono, SH
    Wilson, TJ
    Tymms, MJ
    Venter, DJ
    Corrick, CM
    Kola, R
    Lahoud, MH
    Papas, TS
    Seth, A
    Kola, I
    [J]. NATURE, 1996, 379 (6565) : 534 - 537
  • [3] Functional genetic polymorphisms in SIM2 and ETS2: Role in Down syndrome
    Chatterjee, Arpita
    Dutta, Samikshan
    Sinha, Swagata
    Mukhopadhyay, Kanchan
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2012, 30 (08) : 655 - 655
  • [4] Complex Contributions of Ets2 to Craniofacial and Thymus Phenotypes of Trisomic "Down Syndrome" Mice
    Hill, Cheryl A.
    Sussan, Thomas E.
    Reeves, Roger H.
    Richtsmeier, Joan T.
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2009, 149A (10) : 2158 - 2165
  • [5] Exploratory investigation on functional significance of ETS2 and SIM2 genes in Down syndrome
    Chatterjee, Arpita
    Dutta, Samikshan
    Sinha, Swagata
    Mukhopadhyay, Kanchan
    [J]. DISEASE MARKERS, 2011, 31 (05) : 247 - 257
  • [6] ETS2 Loss of Expression in Prostate Cancer
    Segales Tana, Laura
    Lloreta-Trull, Josep
    Juanpere-Rodero, Nuria
    Lorenzo, Marta
    Fumado, Lluis
    Cecchini, Lluis
    Hernandez-Llodra, Silvia
    [J]. MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 969 - 969
  • [7] Potential contribution of SIM2 and ETS2 functional polymorphisms in Down syndrome associated malignancies
    Chatterjee, Arpita
    Dutta, Samikshan
    Mukherjee, Sanjit
    Mukherjee, Nupur
    Dutta, Avirup
    Mukherjee, Ashis
    Sinha, Swagata
    Panda, Chinmay Kumar
    Chaudhuri, Keya
    Roy, Ananda L.
    Mukhopadhyay, Kanchan
    [J]. BMC MEDICAL GENETICS, 2013, 14
  • [8] The chromosome 21 transcription factor ETS2 transactivates the β-APP promoter:: implications for Down syndrome
    Wolvetang, EW
    Bradfield, OM
    Tymms, M
    Zavarsek, S
    Hatzistavrou, T
    Kola, I
    Hertzog, PJ
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2003, 1628 (02): : 105 - 110
  • [9] ETS2 Loss of Expression in Prostate Cancer
    Tana, Laura Segales
    Lloreta-Trull, Josep
    Juanpere-Rodero, Nuria
    Lorenzo, Marta
    Fumado, Lluis
    Cecchini, Lluis
    Hernandez-Llodra, Silvia
    [J]. LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 969 - 969
  • [10] Expression of the transcription factor ETS2 in brain of patients with Down Syndrome - evidence against the overexpression-gene dosage hypothesis
    Greber-Platzer, S
    Schatzmann-Turhani, D
    Cairns, N
    Balcz, B
    Lubec, G
    [J]. JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1999, (57): : 269 - 281